Statistician
Philips Health Centre, Eindhoven, Holland Influenza must be regarded as a serious disease. The mortality it occasions is difficult to determine exactly, because a diagnosis of influenza can never be made with certainty on the basis of clinical observation alone.
Figures for excess mortality during pandemics and epidemics reveal that, though greatly reduced by progress in methods of treatment, the number of deaths caused by the disease is still fairly large. ' 3 During the 1957 pandemic the death rate in the Netherlands, Britain, and the U.S.A. was I per 2,000 to 4,000 head of population.4-6 These high death rates are by no means confined to pandemic years but also occur during ordinary epidemics, as will be clear from Table 1 .7 The drastic effect of influenza on sick-absence figures is evident from Fig. 1 . In view of its high mortality and morbidity rates, determined action against influenza is called for. Vaccination is so far the only form of prevention the effectiveness of which has been demonstrated.
In practice there is a great deal of difficulty in proving that influenza vaccinations have actually yielded positive results: the clinical picture may be so similar to those of other acute diseases of the respiratory passages that differential diagnosis is possible only with the aid of complicated and costly laboratory tests, such as those whereby the virus is shown to be present in garglings or whereby antibodies are demonstrated in the blood. It has been possible, in investigations in which these methods were employed, to demonstrate whether vaccination has or has not been effective in a given case. Vaccination against influenza is at present thought to be effective in 65 to 75% of cases. 8 22 In circumstances where vaccination of industrial employees is undertaken as a routine, elaborate laboratory methods are impracticable and an attempt must be made to ascertain the effect of the vaccinations in some other manner. One obvious yardstick is sickness absence. We have acquired some experience in the use of it since 1949, in which year workers in the Dutch Philips factories were vaccinated against influenza for the first time.
It has been found that a number of requirements must be satisfied if the sick-absence method is to provide reliable results.
1. The recording of the sick-absence data must be absolutely accurate.
2. Absence due to influenza cannot itself be made the yardstick, as it is practically impossible to diagnose the disease with a sufficient degree of certainty. 3. Absence due to acute respiratory diseases cannot be taken as a yardstick either, unless the number of spells recorded under the heading " diagnosis unknown " is sufficiently small.
4. The spells of sick absence must be recorded for males and females separately, as the absence rates for the two sexes may differ considerably (see Table 11 ).
5. Absences must be recorded by age-groups, because young people tend to be absent more often than older people (Table II) . The latter, however, are away for much longer periods than young people are. Furthermore, absences on account of acute respiratory diseases are not always equally distributed over the age-groups (Table II) . It is practically impossible to demonstrate that vaccination has or has not had any effect in groups comprising fewer than 100 persons. In groups comprising 100 to 500 persons it is sometimes possible to draw sufficiently reliable conclusions from the data. Preferably, however, the groups should be made up of at least 1,000 persons (see Table IV Periods of Observation During the epidemic the P.P.R.s of 27 groups reached a peak significantly higher than the relevant average P.P.R. levels. For 18 of these groups the peak occurred in week 8 (February 22 to 28, 1960, inclusive); for nine of them it occurred in the weeks immediately preceding or following. The index used to determine the effect of vaccination is the incidence rate (210),* abbreviated I.R., that being the number of spells of absence (irrespective of diagnosis) beginning during a specific week, expressed as a percentage of the number of persons under observation. The I.R. attains its peak some days before the P.P.R. does, and with this fact in mind we chose for each group a period of observation that included the week in which that particular group's P.P.R. reached a peak, and the two preceding weeks and the week following. Weeks 6, 7, 8, and 9 constituted the observation period chosen for groups whose P.P.R. showed no pronounced peak.
Yardstick Taken for Effect of Vaccination
During an influenza epidemic the I.R. is made up of two components: one, the basic incidence rate, or B.I.R., relates to absences not caused by influenza, either directly or indirectly; the other component, the extra incidence rate, or E.l.R., relates to absences caused by influenza. Any effect the vaccination may have will manifest itself in the E.I.R., not in the B.I.R. We thus have the following arithmetical relationships (see Fig. 2 All the values of R calculated per group have been influenced to some extent by chance events, and consequently they will not be the same as the true index for the effect of vaccination, which we may call R 1.
With a view to getting an impression of the influence of chance events, 95% confidence intervals were calculated; they are set out in Table IV . The limits have been fixed in such a way that there is a probability of 95% that R 1 will fall within the interval worked out from the observed values.* In general, chance events have a smaller influence on results obtained from large groups than those obtained from small groups. Hence R values calculated for large groups represent a more reliable estimate of R 1, the true measure of the effect of vaccination. The confidence interval for a large group is normally narrower than one for a small group, and so permits of more strictly formulated conclusions.
Results
The results for the 35 groups have been assembled in Table IV . Part I relates to three groups in which sick absences failed to provide any evidence of an influenza epidemic. One remarkable fact is that an epidemic pattern was displayed by sick absences among men working in factories 2 and 3 but not by those of female employees in the same factories. The remaining 32 groups have been divided into three categories in accordance with the number of vaccinated persons they contain. It is clear that this number (if it represents less than 50% of employees) must be at least about 1,000 if the confidence interval is to be narrow enough to allow reasonably accurate conclusions to be drawn. It is seldom possible to draw such conclusions from data for smaller groups.
Results for the largest groups would indicate that the reduction in the E.l.R. can be assessed at 65 to 70%. The results for the smaller groups are not in conflict with this assessment. This would imply that vaccination resulted in a saving of 8,200 working days, or a good 70 days per 100 vaccinated persons-a saving that amply makes up for the expense incurred.
It has not been possible to determine with sufficient certainty the influence exercised by age on the I.R.s of vaccinated and non-vaccinated persons during the fourweek observation periods. Summary The effect of an inactivated influenza vaccine on the "extra incidence rate" during an influenza epidemic was determined by studying sick absences in 35 groups, each made up of vaccinated and non-vaccinated persons and together comprising more than 45,000 persons, of whom more than 11,000 had been vaccinated.
The Of recent years there has been a change in the medical management of ulcerative colitis, and steroid therapy has been found to be useful in many cases (Truelove and Witts, 1955) . Refinement and possibly improvement in treatment has been reported with the use of hydrocortisone intrarectally by slow infusion (Truelove, 1956 (Truelove, , 1957 (Truelove, , 1958 and prednisolone intrarectally from a plastic bag in one injection (Matts, 1960a (Matts, , 1960b (Matts, , 1961a ).
Reports of the use of steroids in fulminating colitis are few. In the series presented by Lennard-Jones and Vivian (1960) only seven cases were treated in the fulminating episode with large doses of either A.C.T.H. or cortisone. Only two of these were found to improve as a result of this treatment. Truelove (1960b) reports more encouraging results using local hydrocortisone either alone or combined with systemic steroids. All his five cases reported in detail improved on treatment. Further, he cited a sharp fall in the in-patient mortality rate of ulcerative colitis patients during the years topical steroids had been used at the Radcliffe Infirmary. As the results of management of ulcerative colitis in general with steroids have been so good (Truelove, 1956 (Truelove, , 1957 (Truelove, , 1958 (Truelove, , 1960a Watkinson, 1958; Matts, 1960a Matts, , 1960b Matts, , 1961a it would appear that their use in fulminating colitis is worth considering. Accordingly a group of 12 patients have been treated with combined A.C.T.H. by injection and intrarectal prednisolone.
